An Overview on Paclitaxel in Advanced Chemotherapy

Published on:
Indian Journal of Pharmacy Practice, 2010; 3(3):1-7
Review Articles | doi:Nil


An Overview on Paclitaxel in Advanced Chemotherapy


Authors and affiliation (s):

Subash V*, Venkateswarlu B, Fareedullah Md, Sudhakar Y

Department of Pharmacy Practice, MGM Hospital, Warangal, A.P, India

Abstract:

Paclitaxel is a new cytotoxic agent that has demonstrated significant activity in advanced ovarian, breast, lung, head and neck cancer. The chemotherapy remains problematic and ineffective because of the problems of poor efficacy, parasite resistance, high toxicity, high cost and unavailability of drug in larger hospital. Therefore there is an urgent need for review drug therapy and efficacious of paclitaxel. We developed a search engine to find any literature about pharmacokinetic parameters of paclitaxel and its drug treatment in DOAJ database, Science Direct, and PubMed using the key phrases paclitaxel; drug therapy; adverse drug reactions and pharmacokinetics. Our results shows that efficacy, neurotoxicity and application of paclitaxel. Hence our review concludes that, about the importance and implementation of therapeutic drug monitoring in individualization of chemotherapy in various cancer patients.

Key words: Paclitaxel, Pharmacokinetic, Cancer, Chemotherapy




 

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmacy Practice (IJOPP) [ISSN-0974-8326] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 2008.

DOI HISTORY

IJOPP uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2014 are being assigned DOIs for its permanent URLs